FDA Drug Recalls

Recalls / Brands / Jardiance

Jardiance

2 FDA drug recalls involving brand “Jardiance”.

DateClassProductFirm
2023-03-09Class IIJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-Boehringer Ingelheim Pharmaceuticals, Inc.
2022-01-26Class IIJardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, DistribuCARDINAL HEALTHCARE